Exhibit | ||||||||
99.1 | ||||||||
99.2 | ||||||||
99.3 |
||||||||
99.4 |
||||||||
99.5 |
Sangoma Technologies Corporation | |||||||||||
Date: May 8, 2025 |
By: | /s/ Larry Stock | |||||||||
Name: Larry Stock | |||||||||||
Title: Chief Financial Officer |
Condensed consolidated interim statements of financial position |
|||||
Condensed consolidated interim statements of loss and comprehensive loss |
|||||
Condensed consolidated interim statements of changes in shareholders’ equity |
|||||
Condensed consolidated interim statements of cash flows |
|||||
Notes to the condensed consolidated interim financial statements |
Sangoma Technologies Corporation | ||
Condensed consolidated interim statements of financial position | ||
As at March 31, 2025, and June 30, 2024 | ||
(Unaudited in thousands of US dollars, except per share data) |
March 31, | June 30, | |||||||||||||
Note | 2025 | 2024 | ||||||||||||
$ | $ | |||||||||||||
Assets | ||||||||||||||
Current assets | ||||||||||||||
Cash and cash equivalents | 4 | 17,291 | 16,231 | |||||||||||
Trade and other receivables | 4 | 9,943 | 18,596 | |||||||||||
Inventories | 6 | 9,716 | 14,768 | |||||||||||
Sales tax receivable | 263 | 485 | ||||||||||||
Income tax receivable | 277 | 956 | ||||||||||||
Contract assets | 1,239 | 1,479 | ||||||||||||
Derivative assets | 15 | 312 | 727 | |||||||||||
Assets held for sale | 20 | 5,324 | — | |||||||||||
Other current assets | 3,992 | 3,867 | ||||||||||||
48,357 | 57,109 | |||||||||||||
Non-current assets | ||||||||||||||
Property and equipment | 7 | 6,638 | 8,394 | |||||||||||
Right-of-use assets | 8 | 8,182 | 10,164 | |||||||||||
Intangible assets | 9 | 99,296 | 124,128 | |||||||||||
Development costs | 10 | 7,715 | 7,810 | |||||||||||
Deferred income tax assets | 2,032 | 2,334 | ||||||||||||
Goodwill | 12 | 186,841 | 187,502 | |||||||||||
Contract assets | 1,919 | 2,418 | ||||||||||||
Derivative assets | 15 | 86 | 320 | |||||||||||
Other non-current assets | 369 | 466 | ||||||||||||
361,435 | 400,645 | |||||||||||||
Liabilities | ||||||||||||||
Current liabilities | ||||||||||||||
Accounts payable and accrued liabilities | 4,17(i) |
19,007 | 21,450 | |||||||||||
Provisions | 13 | 290 | 405 | |||||||||||
Sales tax payable | 4,050 | 5,955 | ||||||||||||
Income tax payable | 138 | 115 | ||||||||||||
Operating facility and loans | 15 | 20,600 | 19,875 | |||||||||||
Contract liabilities | 16 | 7,130 | 9,582 | |||||||||||
Liabilities directly associated with assets held for sale | 20 | 2,496 | — | |||||||||||
Lease obligations on right-of-use assets | 8 | 2,013 | 2,722 | |||||||||||
55,724 | 60,104 | |||||||||||||
Long term liabilities | ||||||||||||||
Operating facility and loans | 15 | 32,450 | 57,950 | |||||||||||
Contract liabilities | 16 | 2,714 | 3,072 | |||||||||||
Non-current lease obligations on right-of-use assets | 8 | 7,237 | 8,562 | |||||||||||
Deferred income tax liabilities | 6,166 | 9,895 | ||||||||||||
Other non-current liabilities | 1,887 | 1,332 | ||||||||||||
106,178 | 140,915 | |||||||||||||
Shareholders’ equity | ||||||||||||||
Share capital | 382,596 | 380,986 | ||||||||||||
Contributed surplus | 19,699 | 20,053 | ||||||||||||
Accumulated other comprehensive income | 116 | 626 | ||||||||||||
Accumulated deficit | (147,154) | (141,935) | ||||||||||||
255,257 | 259,730 | |||||||||||||
361,435 | 400,645 |
Approved by the Board | ||||||||
(Signed) | Al Guarino | Director | ||||||
(Signed) | Allan Brett | Director | ||||||
Sangoma Technologies Corporation | ||
Condensed consolidated interim statements of loss and comprehensive loss | ||
For the three and nine month periods ended March 31, 2025 and 2024 | ||
(Unaudited in thousands of US dollars, except per share data) |
Three month periods ended | Nine month periods ended | ||||||||||||||||
March 31, | March 31, | ||||||||||||||||
Note | 2025 | 2024 | 2025 | 2024 | |||||||||||||
$ | $ | $ | $ | ||||||||||||||
Revenue | 19 | 58,067 | 61,046 | 177,330 | 186,350 | ||||||||||||
Cost of sales | 18,028 | 18,046 | 55,622 | 55,336 | |||||||||||||
Gross profit | 40,039 | 43,000 | 121,708 | 131,014 | |||||||||||||
Expenses | |||||||||||||||||
Sales and marketing | 12,949 | 13,653 | 38,104 | 44,822 | |||||||||||||
Research and development | 10 | 10,466 | 10,189 | 32,131 | 29,509 | ||||||||||||
General and administration | 8,991 | 10,652 | 29,126 | 32,978 | |||||||||||||
Amortization of intangible assets | 9 | 8,199 | 8,251 | 24,596 | 24,974 | ||||||||||||
Interest expense (net) | 4,15 |
871 | 1,718 | 3,354 | 5,175 | ||||||||||||
Restructuring and business integration costs | 272 | — | 514 | 1,491 | |||||||||||||
Loss on change in fair value of consideration payable | 14 | — | — | — | 202 | ||||||||||||
Loss before income tax | (1,709) | (1,463) | (6,117) | (8,137) | |||||||||||||
Provision for income taxes | |||||||||||||||||
Current | 11 | 1,092 | 1,135 | 2,466 | 1,799 | ||||||||||||
Deferred | 11 | (1,373) | (1,330) | (3,364) | (2,985) | ||||||||||||
Net loss | (1,428) | (1,268) | (5,219) | (6,951) | |||||||||||||
Other comprehensive (loss) income |
|||||||||||||||||
Items to be reclassified to net (loss) income |
|||||||||||||||||
Change in fair value of interest rate swaps, net of tax | 11,15 |
(112) | 39 | (510) | (535) | ||||||||||||
Comprehensive loss | (1,540) | (1,229) | (5,729) | (7,486) | |||||||||||||
Loss per share | |||||||||||||||||
Basic and diluted | 17(iii) |
$ | (0.04) | $ | (0.04) | $ | (0.16) | $ | (0.21) | ||||||||
Weighted average number of shares outstanding | |||||||||||||||||
Basic and diluted | 17(iii) |
33,437,452 | 33,156,525 | 33,521,932 | 33,249,351 | ||||||||||||
Sangoma Technologies Corporation | ||
Condensed consolidated interim statements of changes in shareholders' equity | ||
For the nine month periods ended March 31, 2025 and 2024 | ||
(Unaudited in thousands of US dollars, except per share data) |
Note | Number of common shares | Share capital | Contributed surplus | Accumulated other comprehensive earnings | Retained earnings (accumulated deficit) | Total shareholders' equity | |||||||||||||||||
# | $ | $ | $ | $ | $ | ||||||||||||||||||
Balance, July 1, 2023 | 33,038,367 | 379,924 | 18,132 | 1,335 | (133,276) | 266,115 | |||||||||||||||||
Net loss | — | — | — | — | (6,951) | (6,951) | |||||||||||||||||
Change in fair value of interest rate swaps, net of tax | 15 |
— | — | — | (535) | — | (535) | ||||||||||||||||
Common shares issued for RSU exercised | 17(i),17(ii) |
294,500 | 1,020 | (1,020) | — | — | — | ||||||||||||||||
Share-based compensation expense | 17(ii) |
— | — | 2,282 | — | — | 2,282 | ||||||||||||||||
Balance, March 31, 2024 |
33,332,867 | 380,944 | 19,394 | 800 | (140,227) | 260,911 | |||||||||||||||||
Balance, July 1, 2024 |
33,340,159 | 380,986 | 20,053 | 626 | (141,935) | 259,730 | |||||||||||||||||
Net loss | — | — | — | — | (5,219) | (5,219) | |||||||||||||||||
Change in fair value of interest rate swaps, net of tax | 15 |
— | — | — | (510) | — | (510) | ||||||||||||||||
Common shares issued for RSU exercised | 17(i),17(ii) |
304,933 | 1,688 | (1,688) | — | — | — | ||||||||||||||||
Common shares purchased and cancelled | 17(i) |
(17,529) | (78) | — | — | — | (78) | ||||||||||||||||
Shares repurchase commitments under the automatic share purchase plan | 17(i) |
— | — | (949) | — | — | (949) | ||||||||||||||||
Share-based compensation expense | 17(ii) | — | — | 2,283 | — | — | 2,283 | ||||||||||||||||
Balance, March 31, 2025 |
33,627,563 | 382,596 | 19,699 | 116 | (147,154) | 255,257 |
Sangoma Technologies Corporation | ||
Condensed consolidated interim statements of cash flows | ||
For the nine month periods ended March 31, 2025 and 2024 | ||
(Unaudited in thousands of US dollars, except per share data) |
Nine month periods ended | |||||||||||
March 31, | |||||||||||
Note | 2025 | 2024 | |||||||||
Operating activities | $ | $ | |||||||||
Net loss | (5,219) | (6,951) | |||||||||
Adjustments for: | |||||||||||
Depreciation of property and equipment | 7 | 3,073 | 3,292 | ||||||||
Depreciation of right-of-use assets | 8 | 1,971 | 2,206 | ||||||||
Amortization of intangible assets | 9 | 24,596 | 24,974 | ||||||||
Amortization of development costs | 10 | 4,516 | 3,200 | ||||||||
Income tax recovery | 11 | (898) | (1,186) | ||||||||
Income tax refunds (paid) | (1,157) | 1,374 | |||||||||
Share-based compensation expense | 17(ii) |
2,283 | 2,282 | ||||||||
Unrealized foreign exchange loss | (28) | (144) | |||||||||
Accretion expense | 8 |
234 | 303 | ||||||||
Loss on disposal of property and equipment | 7 | 186 | 296 | ||||||||
Loss on change in fair value of consideration payable | 14 | — | 202 | ||||||||
Changes in working capital | |||||||||||
Trade and other receivables | 6,845 | 2,188 | |||||||||
Inventories | 2,679 | 1,795 | |||||||||
Sales tax receivable | 222 | (68) | |||||||||
Contract assets | 739 | 574 | |||||||||
Other assets | (162) | 401 | |||||||||
Sales tax payable | (1,897) | 988 | |||||||||
Accounts payable and accrued liabilities | (1,273) | (2,355) | |||||||||
Provisions | (115) | 199 | |||||||||
Other non current liabilities | 875 | 723 | |||||||||
Contract liabilities | (2,810) | (1,750) | |||||||||
Net cash provided by operating activities | 34,660 | 32,543 | |||||||||
Investing activities | |||||||||||
Purchase of property and equipment | 7 | (1,569) | (2,695) | ||||||||
Development costs | 10 | (4,938) | (4,819) | ||||||||
Net cash flows used in investing activities | (6,507) | (7,514) | |||||||||
Financing activities | |||||||||||
Repayments of operating facility and loan | 15 | (24,775) | (13,275) | ||||||||
Repayment of lease obligations on right-of-use assets | 8 | (2,240) | (2,425) | ||||||||
Payment of consideration payable | 14 | — | (2,096) | ||||||||
Common shares purchased and cancelled | 17(i) |
(78) | — | ||||||||
Net cash flows used in financing activities | (27,093) | (17,796) | |||||||||
Increase in cash and cash equivalents | 1,060 | 7,233 | |||||||||
Cash and cash equivalents, beginning of the period |
16,231 | 11,156 | |||||||||
Cash and cash equivalents, end of the period |
17,291 | 18,389 |
Sangoma Technologies Corporation | ||
Notes to the condensed consolidated interim financial statements | ||
For the three and nine month periods ended March 31, 2025 and 2024 | ||
(Unaudited in thousands of US dollars, except per share data) |
Sangoma Technologies Corporation | ||
Notes to the condensed consolidated interim financial statements | ||
For the three and nine month periods ended March 31, 2025 and 2024 | ||
(Unaudited in thousands of US dollars, except per share data) |
March 31, | June 30, | |||||||
2025 | 2024 | |||||||
$ | $ | |||||||
Cash at bank and on hand | 16,668 | 16,231 | ||||||
Restricted cash | 623 | — | ||||||
Cash and cash equivalents | 17,291 | 16,231 |
Sangoma Technologies Corporation | ||
Notes to the condensed consolidated interim financial statements | ||
For the three and nine month periods ended March 31, 2025 and 2024 | ||
(Unaudited in thousands of US dollars, except per share data) |
Three month periods ended | Nine month periods ended | |||||||||||||||||||
March 31, | March 31, | |||||||||||||||||||
Note | 2025 | 2024 | 2025 | 2024 | ||||||||||||||||
$ | $ | $ | $ | |||||||||||||||||
Interest income | (72) | (5) | (93) | (19) | ||||||||||||||||
Interest expense | 15 | 870 | 1,630 | 3,213 | 4,891 | |||||||||||||||
Accretion expense | 8 |
73 | 93 | 234 | 303 | |||||||||||||||
Interest expense (net) | 871 | 1,718 | 3,354 | 5,175 |
March 31, | June 30, | |||||||||||||
2025 | 2024 | |||||||||||||
$ | $ | |||||||||||||
Trade receivables | 9,943 | 16,025 | ||||||||||||
Receivable related to working capital adjustment | — | 2,571 | ||||||||||||
Trade and other receivables | 9,943 | 18,596 |
Sangoma Technologies Corporation | ||
Notes to the condensed consolidated interim financial statements | ||
For the three and nine month periods ended March 31, 2025 and 2024 | ||
(Unaudited in thousands of US dollars, except per share data) |
March 31, | June 30, | |||||||
2025 | 2024 | |||||||
$ | $ | |||||||
Trade receivables aging: | ||||||||
0-30 days | 8,127 | 12,229 | ||||||
31-90 days | 1,721 | 2,995 | ||||||
Greater than 90 days | 990 | 2,170 | ||||||
10,838 | 17,394 | |||||||
Expected credit loss provision | (895) | (1,369) | ||||||
Net trade receivables | 9,943 | 16,025 |
March 31, | June 30, | |||||||
2025 | 2024 | |||||||
$ | $ | |||||||
Expected credit loss provision: | ||||||||
Expected credit loss provision, beginning balance | (1,369) | (1,566) | ||||||
Net change in expected credit loss provision during the period |
474 | 197 | ||||||
Expected credit loss provision, ending balance | (895) | (1,369) |
Sangoma Technologies Corporation | ||
Notes to the condensed consolidated interim financial statements | ||
For the three and nine month periods ended March 31, 2025 and 2024 | ||
(Unaudited in thousands of US dollars, except per share data) |
within 12 months | 13-24 months | 25-36 months | >36 months | Total | |||||||||||||
$ | $ | $ | $ | $ | |||||||||||||
Accounts payable and accrued liabilities | 19,007 | — | — | — | 19,007 | ||||||||||||
Sales tax payable | 4,050 | — | — | — | 4,050 | ||||||||||||
Operating facility and loans | 20,600 | 20,600 | 11,850 | — | 53,050 | ||||||||||||
Lease obligations on right of use assets | 2,303 | 1,792 | 1,348 | 4,782 | 10,225 | ||||||||||||
Other non-current liabilities | — | — | — | 1,887 | 1,887 | ||||||||||||
45,960 | 22,392 | 13,198 | 6,669 | 88,219 |
Sangoma Technologies Corporation | ||
Notes to the condensed consolidated interim financial statements | ||
For the three and nine month periods ended March 31, 2025 and 2024 | ||
(Unaudited in thousands of US dollars, except per share data) |
March 31, | June 30, | |||||||
2025 | 2024 | |||||||
$ | $ | |||||||
Finished goods | 5,755 | 10,740 | ||||||
Components and parts | 5,584 | 5,537 | ||||||
11,339 | 16,277 | |||||||
Provision for obsolescence | (1,623) | (1,509) | ||||||
Net inventory carrying value | 9,716 | 14,768 |
Sangoma Technologies Corporation | ||
Notes to the condensed consolidated interim financial statements | ||
For the three and nine month periods ended March 31, 2025 and 2024 | ||
(Unaudited in thousands of US dollars, except per share data) |
Office furniture | Stockroom | ||||||||||||||||||||||
and computer | Software | and production | Tradeshow | Leasehold | |||||||||||||||||||
Note | equipment | equipment | equipment | improvements | Total | ||||||||||||||||||
Cost | $ | $ | $ | $ | $ | $ | |||||||||||||||||
Balance at July 1, 2023 |
5,366 | 458 | 12,867 | 47 | 450 | 19,188 | |||||||||||||||||
Additions | 660 | 42 | 3,368 | — | 60 | 4,130 | |||||||||||||||||
Disposals | (52) | — | (579) | — | — | (631) | |||||||||||||||||
Balance at June 30, 2024 |
5,974 | 500 | 15,656 | 47 | 510 | 22,687 | |||||||||||||||||
Additions | 329 | — | 1,240 | — | — | 1,569 | |||||||||||||||||
Disposals | (3) | — | (572) | — | — | (575) | |||||||||||||||||
Reclassification to assets held for sale | 20 | (113) | (82) | — | — | — | (195) | ||||||||||||||||
Balance at March 31, 2025 |
6,187 | 418 | 16,324 | 47 | 510 | 23,486 | |||||||||||||||||
Accumulated depreciation | |||||||||||||||||||||||
Balance at July 1, 2023 |
3,364 | 434 | 5,906 | 47 | 285 | 10,036 | |||||||||||||||||
Depreciation expense | 815 | 22 | 3,539 | — | 119 | 4,495 | |||||||||||||||||
Disposals | — | — | (238) | — | — | (238) | |||||||||||||||||
Balance at June 30, 2024 |
4,179 | 456 | 9,207 | 47 | 404 | 14,293 | |||||||||||||||||
Depreciation expense | 548 | 15 | 2,480 | — | 30 | 3,073 | |||||||||||||||||
Disposals | — | — | (389) | — | — | (389) | |||||||||||||||||
Reclassification to assets held for sale | 20 | (74) | (55) | — | — | — | (129) | ||||||||||||||||
Balance at March 31, 2025 |
4,653 | 416 | 11,298 | 47 | 434 | 16,848 | |||||||||||||||||
Net book value as at: | |||||||||||||||||||||||
Balance at June 30, 2024 |
1,795 | 44 | 6,449 | — | 106 | 8,394 | |||||||||||||||||
Balance at March 31, 2025 |
1,534 | 2 | 5,026 | — | 76 | 6,638 |
Sangoma Technologies Corporation | ||
Notes to the condensed consolidated interim financial statements | ||
For the three and nine month periods ended March 31, 2025 and 2024 | ||
(Unaudited in thousands of US dollars, except per share data) |
Note | Right-of-use assets | |||||||
$ | ||||||||
Present value of leases | ||||||||
Balance as at July 1, 2023 |
22,182 | |||||||
Additions | 814 | |||||||
Terminations | (3,239) | |||||||
Balance at June 30, 2024 |
19,757 | |||||||
Additions | 93 | |||||||
Terminations | (601) | |||||||
Reclassification to assets held for sale | 20 | (1,149) | ||||||
Balance at March 31, 2025 |
18,100 | |||||||
Accumulated depreciation and repayments | ||||||||
Balance as at July 1, 2023 |
9,030 | |||||||
Depreciation expense | 2,870 | |||||||
Terminations | (2,307) | |||||||
Balance at June 30, 2024 |
9,593 | |||||||
Depreciation expense | 1,971 | |||||||
Terminations | (543) | |||||||
Reclassification to assets held for sale | 20 | (1,103) | ||||||
Balance at March 31, 2025 |
9,918 | |||||||
Net book value as at: | ||||||||
June 30, 2024 | 10,164 | |||||||
March 31, 2025 | 8,182 |
Sangoma Technologies Corporation | ||
Notes to the condensed consolidated interim financial statements | ||
For the three and nine month periods ended March 31, 2025 and 2024 | ||
(Unaudited in thousands of US dollars, except per share data) |
Note | Lease obligations | |||||||
$ | ||||||||
Present value of leases | ||||||||
Balance as at July 1, 2023 |
14,331 | |||||||
Additions | 814 | |||||||
Repayments | (3,163) | |||||||
Accretion expense | 394 | |||||||
Terminations | (1,086) | |||||||
Effects of movements on exchange rates | (6) | |||||||
Balance at June 30, 2024 |
11,284 | |||||||
Additions | 93 | |||||||
Repayments | (2,240) | |||||||
Accretion expense | 234 | |||||||
Terminations | (68) | |||||||
Effects of movements on exchange rates | (4) | |||||||
Reclassification to liabilities directly associated with assets held for sale | 20 | (49) | ||||||
Balance at March 31, 2025 |
9,250 | |||||||
Lease Obligations - Current | 2,013 | |||||||
Lease Obligations - Non-current | 7,237 | |||||||
9,250 |
Sangoma Technologies Corporation | ||
Notes to the condensed consolidated interim financial statements | ||
For the three and nine month periods ended March 31, 2025 and 2024 | ||
(Unaudited in thousands of US dollars, except per share data) |
Other | ||||||||||||||||||||
Purchased | Customer | purchased | ||||||||||||||||||
Note | technology | relationships | Brand | intangibles | Total | |||||||||||||||
$ | $ | $ | $ | $ | ||||||||||||||||
Cost | ||||||||||||||||||||
Balance at July 1, 2023 |
110,123 | 126,456 | 6,787 | 2,748 | 246,114 | |||||||||||||||
Balance at June 30, 2024 |
110,123 | 126,456 | 6,787 | 2,748 | 246,114 | |||||||||||||||
Reclassification to assets held for sale | 20 | — | (1,160) | (1,050) | — | (2,210) | ||||||||||||||
Balance at March 31, 2025 |
110,123 | 125,296 | 5,737 | 2,748 | 243,904 | |||||||||||||||
Accumulated amortization | ||||||||||||||||||||
Balance at July 1, 2023 |
41,576 | 40,821 | 3,586 | 2,694 | 88,677 | |||||||||||||||
Amortization expense | 17,683 | 14,948 | 624 | 54 | 33,309 | |||||||||||||||
Balance at June 30, 2024 |
59,259 | 55,769 | 4,210 | 2,748 | 121,986 | |||||||||||||||
Amortization expense | 13,039 | 11,095 | 462 | — | 24,596 | |||||||||||||||
Reclassification to assets held for sale | 20 | — | (1,160) | (814) | — | (1,974) | ||||||||||||||
Balance at March 31, 2025 |
72,298 | 65,704 | 3,858 | 2,748 | 144,608 | |||||||||||||||
Net book value as at: | ||||||||||||||||||||
Balance at June 30, 2024 |
50,864 | 70,687 | 2,577 | — | 124,128 | |||||||||||||||
Balance at March 31, 2025 |
37,825 | 59,592 | 1,879 | — | 99,296 |
Sangoma Technologies Corporation | ||
Notes to the condensed consolidated interim financial statements | ||
For the three and nine month periods ended March 31, 2025 and 2024 | ||
(Unaudited in thousands of US dollars, except per share data) |
Cost | $ | ||||
Balance at July 1, 2023 |
12,051 | ||||
Additions | 6,782 | ||||
Cost fully amortized | (309) | ||||
Investment tax credits | (822) | ||||
Balance at June 30, 2024 |
17,702 | ||||
Additions | 4,938 | ||||
Investment tax credits | (517) | ||||
Balance at March 31, 2025 |
22,123 | ||||
Accumulated amortization | |||||
Balance at July 1, 2023 |
(5,482) | ||||
Amortization | (4,480) | ||||
Cost fully amortized | 70 | ||||
Balance at June 30, 2024 |
(9,892) | ||||
Amortization | (4,516) | ||||
Balance at March 31, 2025 |
(14,408) |
March 31, | June 30, | |||||||
2025 | 2024 | |||||||
$ | $ | |||||||
Net capitalized development costs | 7,715 | 7,810 |
Sangoma Technologies Corporation | ||
Notes to the condensed consolidated interim financial statements | ||
For the three and nine month periods ended March 31, 2025 and 2024 | ||
(Unaudited in thousands of US dollars, except per share data) |
Three month periods ended | Nine month periods ended | |||||||||||||
March 31, | March 31, | |||||||||||||
2025 | 2024 | 2025 | 2024 | |||||||||||
Statutory income tax rate | 25.76% | 25.62% | 25.76% | 25.62% | ||||||||||
$ | $ | $ | $ | |||||||||||
Loss before income tax | (1,709) | (1,463) | (6,117) | (8,137) | ||||||||||
Expected income tax recovery | (441) | (376) | (1,576) | (2,085) | ||||||||||
Difference in foreign tax rates | 2 | 6 | 6 | 19 | ||||||||||
Share based compensation | 133 | 196 | 588 | 585 | ||||||||||
Other non deductible expenses | (34) | (34) | (91) | (96) | ||||||||||
Changes in estimates | 1 | 4 | 2 | 5 | ||||||||||
Scientific Research and Experimental Development (SR&ED) | 21 | (20) | 64 | 24 | ||||||||||
Gain on consideration payable | — | — | — | 51 | ||||||||||
Changes in tax benefits not recognized | 37 | 29 | 109 | 311 | ||||||||||
Income tax recovery | (281) | (195) | (898) | (1,186) | ||||||||||
The Company’s income tax expense is allocated as follows: | $ | $ | $ | $ | ||||||||||
Current tax expense | 1,092 | 1,135 | 2,466 | 1,799 | ||||||||||
Deferred income tax recovery | (1,373) | (1,330) | (3,364) | (2,985) | ||||||||||
Income tax recovery | (281) | (195) | (898) | (1,186) |
Note | $ | |||||||
Balance at July 1, 2023 |
187,502 | |||||||
Balance at June 30, 2024 |
187,502 | |||||||
Reclassification to assets held for sale | 20 | (661) | ||||||
Balance at March 31, 2025 |
186,841 |
Sangoma Technologies Corporation | ||
Notes to the condensed consolidated interim financial statements | ||
For the three and nine month periods ended March 31, 2025 and 2024 | ||
(Unaudited in thousands of US dollars, except per share data) |
$ | |||||
Balance at July 1, 2023 |
237 | ||||
Additional provision recognized | 168 | ||||
Balance at June 30, 2024 |
405 | ||||
Reversed during the period |
(115) | ||||
Balance at March 31, 2025 |
290 |
$ | |||||
Opening balance, July 1, 2023 |
1,894 | ||||
Payments | (2,096) | ||||
Remeasurement during the period |
202 | ||||
Ending balance, June 30, 2024 |
— | ||||
Ending balance, March 31, 2025 |
— | ||||
Sangoma Technologies Corporation | ||
Notes to the condensed consolidated interim financial statements | ||
For the three and nine month periods ended March 31, 2025 and 2024 | ||
(Unaudited in thousands of US dollars, except per share data) |
Sangoma Technologies Corporation | ||
Notes to the condensed consolidated interim financial statements | ||
For the three and nine month periods ended March 31, 2025 and 2024 | ||
(Unaudited in thousands of US dollars, except per share data) |
$ | |||||
Opening balance, July 1, 2023 |
14,551 | ||||
Revenue deferred during the period |
38,500 | ||||
Deferred revenue recognized as revenue during the period |
(40,397) | ||||
Ending balance, June 30, 2024 |
12,654 | ||||
Revenue deferred during the period |
27,909 | ||||
Deferred revenue recognized as revenue during the period |
(30,719) | ||||
Ending balance, March 31, 2025 |
9,844 | ||||
Contract liabilities - Current | 7,130 | ||||
Contract liabilities - Non-current | 2,714 | ||||
9,844 |
Sangoma Technologies Corporation | ||
Notes to the condensed consolidated interim financial statements | ||
For the three and nine month periods ended March 31, 2025 and 2024 | ||
(Unaudited in thousands of US dollars, except per share data) |
Three month periods ended | Nine month periods ended | |||||||||||||
March 31, | March 31, | |||||||||||||
2025 | 2024 | 2025 | 2024 | |||||||||||
# | # | # | # | |||||||||||
Shares issued and outstanding: | ||||||||||||||
Outstanding, beginning of the period |
33,592,534 | 33,325,575 | 33,340,159 | 33,038,367 | ||||||||||
Shares purchased and cancelled | (17,529) | — | (17,529) | — | ||||||||||
Shares issued upon exercise of RSUs | 52,558 | 7,292 | 304,933 | 294,500 | ||||||||||
Outstanding, end of the period |
33,627,563 | 33,332,867 | 33,627,563 | 33,332,867 |
Sangoma Technologies Corporation | ||
Notes to the condensed consolidated interim financial statements | ||
For the three and nine month periods ended March 31, 2025 and 2024 | ||
(Unaudited in thousands of US dollars, except per share data) |
Number | Weighted | |||||||
of options | average price | |||||||
# | $ | |||||||
Balance, July 1, 2023 |
723,051 | 13.58 | ||||||
Forfeited | (239,764) | (10.30) | ||||||
Balance, March 31, 2024 |
483,287 | 15.21 | ||||||
Balance, July 1, 2024 |
462,346 | 15.21 | ||||||
Expired | (42,800) | (11.82) | ||||||
Forfeited | (31,467) | (15.81) | ||||||
Balance, March 31, 2025 |
388,079 | 15.54 |
Sangoma Technologies Corporation | ||
Notes to the condensed consolidated interim financial statements | ||
For the three and nine month periods ended March 31, 2025 and 2024 | ||
(Unaudited in thousands of US dollars, except per share data) |
March 31, | March 31, | |||||||||||||||||||
2025 | 2024 | |||||||||||||||||||
Number of | Weighted | Number of | Weighted | |||||||||||||||||
Number of | stock options | average | Number of | stock options | average | |||||||||||||||
stock options | outstanding and | remaining | stock options | outstanding | remaining | |||||||||||||||
Exercise price | outstanding | exercisable | contractual life | outstanding | and exercisable | contractual life | ||||||||||||||
$7.01 - $9.00 |
88,500 | 61,800 | 2.25 | 122,189 | 53,652 | 3.25 | ||||||||||||||
$9.01 - $12.00 |
62,023 | 59,213 | 0.18 | 81,463 | 62,214 | 1.18 | ||||||||||||||
$12.01 - $15.00 |
42,000 | 31,516 | 2.00 | 45,000 | 22,510 | 3.00 | ||||||||||||||
$15.01 - $18.00 |
106,715 | 100,394 | 1.25 | 124,369 | 85,706 | 2.25 | ||||||||||||||
$18.01 - $20.00 |
22,856 | 20,036 | 1.25 | 22,856 | 14,308 | 2.25 | ||||||||||||||
$20.01 - $27.00 |
65,985 | 65,985 | 0.86 | 87,410 | 65,723 | 1.86 | ||||||||||||||
388,079 | 338,944 | 1.32 | 483,287 | 304,113 | 2.32 |
DSU | PSU | RSU | Total | |||||||||||
Awards outstanding July 1, 2023 |
66,391 | 130,000 | 130,000 | 326,391 | ||||||||||
Awards granted during the period |
105,695 | 404,800 | 797,700 | 1,308,195 | ||||||||||
Awards exercised during the period |
— | — | (294,500) | (294,500) | ||||||||||
Awards forfeited during the period |
— | (42,500) | (26,251) | (68,751) | ||||||||||
Awards outstanding March 31, 2024 |
172,086 | 492,300 | 606,949 | 1,271,335 | ||||||||||
Awards outstanding July 1, 2024 |
172,086 | 499,800 | 607,157 | 1,279,043 | ||||||||||
Awards granted during the period |
64,356 | 271,000 | 271,000 | 606,356 | ||||||||||
Awards exercised during the period |
— | — | (304,933) | (304,933) | ||||||||||
Awards forfeited during the period |
— | (82,500) | (50,623) | (133,123) | ||||||||||
Awards outstanding March 31, 2025 |
236,442 | 688,300 | 522,601 | 1,447,343 |
Nine month periods ended |
||||||||
March 31 | ||||||||
2025 | 2024 | |||||||
Fair value per share | $6.68 |
$3.44 - $4.69 |
||||||
Expected volatility | 64.00% | 64.00% | ||||||
Time to expiry | 2.76 years |
2.36 years -2.83 years |
||||||
Risk-free interest rate | 3.42% | 4.40% |
Sangoma Technologies Corporation | ||
Notes to the condensed consolidated interim financial statements | ||
For the three and nine month periods ended March 31, 2025 and 2024 | ||
(Unaudited in thousands of US dollars, except per share data) |
Three month periods ended | Nine month periods ended | |||||||||||||
March 31, | March 31, | |||||||||||||
2025 | 2024 | 2025 | 2024 | |||||||||||
Number of shares: | ||||||||||||||
Weighted average number of shares outstanding | 33,437,452 | 33,156,525 | 33,521,932 | 33,249,351 | ||||||||||
Weighted average number of shares used in diluted earnings per share | 33,437,452 | 33,156,525 | 33,521,932 | 33,249,351 | ||||||||||
Net loss | $ | (1,428) | $ | (1,268) | $ | (5,219) | $ | (6,951) | ||||||
Loss per share | ||||||||||||||
Basic and diluted | $ | (0.04) | $ | (0.04) | $ | (0.16) | $ | (0.21) | ||||||
Nine month periods ended | ||||||||
March 31, | ||||||||
2025 | 2024 | |||||||
DSU | 236,442 | 172,086 | ||||||
PSU | 688,300 | 492,300 | ||||||
RSU | 522,601 | 606,949 | ||||||
Stock options | 388,079 | 483,287 | ||||||
1,835,422 | 1,754,622 | |||||||
Sangoma Technologies Corporation | ||
Notes to the condensed consolidated interim financial statements | ||
For the three and nine month periods ended March 31, 2025 and 2024 | ||
(Unaudited in thousands of US dollars, except per share data) |
Three month periods ended | Nine month periods ended | |||||||||||||
March 31, | March 31, | |||||||||||||
2025 | 2024 | 2025 | 2024 | |||||||||||
$ | $ | $ | $ | |||||||||||
Products | 9,524 | 10,692 | 30,287 | 34,137 | ||||||||||
Services | 48,543 | 50,354 | 147,043 | 152,213 | ||||||||||
Total revenues | 58,067 | 61,046 | 177,330 | 186,350 |
Three month periods ended | Nine month periods ended | |||||||||||||
March 31, | March 31, | |||||||||||||
2025 | 2024 | 2025 | 2024 | |||||||||||
$ | $ | $ | $ | |||||||||||
USA | 55,165 | 57,093 | 167,588 | 173,796 | ||||||||||
Others | 2,902 | 3,953 | 9,742 | 12,554 | ||||||||||
Total revenues | 58,067 | 61,046 | 177,330 | 186,350 |
March 31, | June 30, | |||||||
2025 | 2024 | |||||||
$ | $ | |||||||
USA | 308,199 | 338,079 | ||||||
Others | 4,879 | 5,457 | ||||||
Total non-current assets | 313,078 | 343,536 |
Sangoma Technologies Corporation | ||
Notes to the condensed consolidated interim financial statements | ||
For the three and nine month periods ended March 31, 2025 and 2024 | ||
(Unaudited in thousands of US dollars, except per share data) |
As At | |||||
March 31, | |||||
2025 | |||||
$ | |||||
Assets | |||||
Current assets | |||||
Trade and other receivables | 1,808 | ||||
Inventories | 2,373 | ||||
Other current assets | 134 | ||||
Property and equipment | 66 | ||||
Right-of-use assets | 46 | ||||
Intangible assets | 236 | ||||
Goodwill | 661 | ||||
Assets held for sale | 5,324 | ||||
Liabilities | |||||
Current liabilities | |||||
Accounts payable and accrued liabilities | 2,119 | ||||
Sales tax payable | 8 | ||||
Lease obligations on right-of-use assets | 49 | ||||
Other non-current liabilities | 320 | ||||
Liabilities directly associated with assets held for sale | 2,496 |
Three month periods ended
March 31,
|
Nine month periods ended
March 31,
|
|||||||||||||||||||||||||
2025 | 2024 | Change | Change | 2025 | 2024 | Change | Change | |||||||||||||||||||
$ | $ | $ | % | $ | $ | $ | % | |||||||||||||||||||
Revenue | 58,067 | 61,046 | (2,979) | (5)% | 177,330 | 186,350 | (9,020) | (5)% | ||||||||||||||||||
Cost of sales | 18,028 | 18,046 | (18) | —% | 55,622 | 55,336 | 286 | 1% | ||||||||||||||||||
Gross profit | 40,039 | 43,000 | (2,961) | (7)% | 121,708 | 131,014 | (9,306) | (7)% | ||||||||||||||||||
Expenses | ||||||||||||||||||||||||||
Sales and marketing | 12,949 | 13,653 | (704) | (5)% | 38,104 | 44,822 | (6,718) | (15)% | ||||||||||||||||||
Research and development | 10,466 | 10,189 | 277 | 3% | 32,131 | 29,509 | 2,622 | 9% | ||||||||||||||||||
General and administration | 8,991 | 10,652 | (1,661) | (16)% | 29,126 | 32,978 | (3,852) | (12)% | ||||||||||||||||||
Amortization of intangible assets | 8,199 | 8,251 | (52) | (1)% | 24,596 | 24,974 | (378) | (2)% | ||||||||||||||||||
Interest expense (net) | 871 | 1,718 | (847) | (49)% | 3,354 | 5,175 | (1,821) | (35)% | ||||||||||||||||||
Restructuring and business integration costs | 272 | — | 272 | 100% | 514 | 1,491 | (977) | (66)% | ||||||||||||||||||
Loss on change in fair value of consideration payable | — | — | — | —% | — | 202 | (202) | (100)% | ||||||||||||||||||
Loss before income tax | (1,709) | (1,463) | (246) | 17% | (6,117) | (8,137) | 2,020 | (25)% | ||||||||||||||||||
Provision for income taxes | ||||||||||||||||||||||||||
Current | 1,092 | 1,135 | (43) | (4)% | 2,466 | 1,799 | 667 | 37% | ||||||||||||||||||
Deferred | (1,373) | (1,330) | (43) | 3% | (3,364) | (2,985) | (379) | 13% | ||||||||||||||||||
Net loss | (1,428) | (1,268) | (160) | 13% | (5,219) | (6,951) | 1,732 | (25)% | ||||||||||||||||||
Other comprehensive income (loss) |
||||||||||||||||||||||||||
Items to be reclassified to net income (loss) |
||||||||||||||||||||||||||
Change in fair value of interest rate swaps, net of tax |
(112) | 39 | (151) | (387)% | (510) | (535) | 25 | (5)% | ||||||||||||||||||
Comprehensive loss | (1,540) | (1,229) | (311) | 25% | (5,729) | (7,486) | 1,757 | (23)% | ||||||||||||||||||
Loss per share |
||||||||||||||||||||||||||
Basic and diluted | $ | (0.04) | $ | (0.04) | $ | — | —% | $ | (0.16) | $ | (0.21) | $ | 0.05 | (24)% | ||||||||||||
Weighted average shares outstanding (thousands) | ||||||||||||||||||||||||||
Basic and diluted | 33,437 | 33,157 | 281 | 1% | 33,522 | 33,249 | 273 | 1% | ||||||||||||||||||
Three month periods ended March 31, |
Three month periods ended December 31, |
Nine month periods ended March 31, |
|||||||||||||||||||||||||||||||||
2025 | 2024 | Change | Change | 2024 | Change | Change | 2025 | 2024 | Change | Change | |||||||||||||||||||||||||
$ | $ | $ | % | $ | $ | % | $ | $ | $ | % | |||||||||||||||||||||||||
Service revenues | 48,543 | 50,354 | (1,811) | (4)% | 48,807 | (264) | (1)% | 147,043 | 152,213 | (5,170) | (3)% | ||||||||||||||||||||||||
Percent of total revenues | 84% | 82% | 2.00% | 2% | 83% | 1% | 1% | 83% | 82% | 1% | 1% | ||||||||||||||||||||||||
Product revenues | 9,524 | 10,692 | (1,168) | (11)% | 10,306 | (782) | (8)% | 30,287 | 34,137 | (3,850) | (11)% | ||||||||||||||||||||||||
Percent of total revenues | 16% | 18% | (2.00)% | (11)% | 17% | (1)% | (1)% | 17% | 18% | (1)% | (6)% | ||||||||||||||||||||||||
Total revenues | 58,067 | 61,046 | (2,979) | (5)% | 59,113 | (1,046) | (2)% | 177,330 | 186,350 | (9,020) | (5)% |
Three month periods ended
March 31,
|
Nine month periods ended
March 31,
|
|||||||||||||||||||||||||
2025 | 2024 | Change | Change | 2025 | 2024 | Change | Change | |||||||||||||||||||
$ | $ | $ | % | $ | $ | $ | % | |||||||||||||||||||
Cost of sales | 18,028 | 18,046 | (18) | —% | 55,622 | 55,336 | 286 | 1% | ||||||||||||||||||
Gross profit | 40,039 | 43,000 | (2,961) | (7)% | 121,708 | 131,014 | (9,306) | (7)% | ||||||||||||||||||
Gross margin | 69% | 70% | (1)% | (1)% | 69% | 70% | (1)% | (1)% |
Three month periods ended
March 31,
|
Nine month periods ended
March 31,
|
|||||||||||||||||||||||||
2025 | 2024 | Change | Change | 2025 | 2024 | Change | Change | |||||||||||||||||||
$ | $ | $ | % | $ | $ | $ | % | |||||||||||||||||||
Sales and marketing | 12,949 | 13,653 | (704) | (5)% | 38,104 | 44,822 | (6,718) | (15)% | ||||||||||||||||||
Research and development | 10,466 | 10,189 | 277 | 3% | 32,131 | 29,509 | 2,622 | 9% | ||||||||||||||||||
General and administration | 8,991 | 10,652 | (1,661) | (16)% | 29,126 | 32,978 | (3,852) | (12)% | ||||||||||||||||||
Amortization of intangible assets | 8,199 | 8,251 | (52) | (1)% | 24,596 | 24,974 | (378) | (2)% | ||||||||||||||||||
Three month periods ended
March 31,
|
Nine month periods ended
March 31,
|
|||||||||||||||||||||||||
2025 | 2024 | Change | Change | 2025 | 2024 | Change | Change | |||||||||||||||||||
$ | $ | $ | % | $ | $ | $ | % | |||||||||||||||||||
Interest expense (net) | 871 | 1,718 | (847) | (49)% | 3,354 | 5,175 | (1,821) | (35)% | ||||||||||||||||||
Restructuring and business integration costs | 272 | — | 272 | 100% | 514 | 1,491 | (977) | (66)% | ||||||||||||||||||
Unaudited in US $000 | Three month periods ended March 31, |
Nine month periods ended March 31, |
||||||||||||||||||||||||
2025 | 2024 | Change | Change | 2025 | 2024 | Change | Change | |||||||||||||||||||
$ | $ | $ | % | $ | $ | $ | % | |||||||||||||||||||
Net cash provided by operating activities | 10,620 | 15,506 | (4,886) | (32)% | 34,660 | 32,543 | 2,117 | 6.5% | ||||||||||||||||||
Purchase of property and equipment | (622) | (1,061) | 439 | (41)% | (1,569) | (2,695) | 1,126 | (41.8)% | ||||||||||||||||||
Development costs | (1,643) | (1,422) | (221) | 16% | (4,938) | (4,819) | (119) | 2.5% | ||||||||||||||||||
Free Cash Flow | 8,355 | 13,023 | (4,668) | (36)% | 28,153 | 25,029 | 3,124 | 12.5% |
Three month periods ended
March 31,
|
Nine month periods ended
March 31,
|
|||||||||||||||||||||||||
2025 | 2024 | Change | Change | 2025 | 2024 | Change | Change | |||||||||||||||||||
$ | $ | $ | % | $ | $ | $ | % | |||||||||||||||||||
Net loss | (1,428) | (1,268) | (160) | 13% | (5,219) | (6,951) | 1,732 | (25)% | ||||||||||||||||||
Tax expense (recovery) | (281) | (195) | (86) | 44% | (898) | (1,186) | 288 | (24)% | ||||||||||||||||||
Interest expense (net) | 871 | 1,718 | (847) | (49)% | 3,354 | 5,175 | (1,821) | (35)% | ||||||||||||||||||
Share-based compensation | 517 | 764 | (247) | (32)% | 2,283 | 2,282 | 1 | —% | ||||||||||||||||||
Depreciation of property and equipment | 982 | 1,169 | (187) | (16)% | 3,073 | 3,292 | (219) | (7)% | ||||||||||||||||||
Depreciation of right-of-use assets | 640 | 716 | (76) | (11)% | 1,971 | 2,206 | (235) | (11)% | ||||||||||||||||||
Amortization of intangibles | 8,199 | 8,251 | (52) | (1)% | 24,596 | 24,974 | (378) | (2)% | ||||||||||||||||||
Restructuring and business integration costs | 272 | — | 272 | 100% | 514 | 1,491 | (977) | (66)% | ||||||||||||||||||
Loss on change in fair value of consideration payable | — | — | — | —% | — | 202 | (202) | (100)% | ||||||||||||||||||
Adjusted EBITDA | 9,772 | 11,155 | (1,383) | (12)% | 29,674 | 31,485 | (1,811) | (6)% | ||||||||||||||||||
Percentage of revenue | 17% | 18% | (1)% | (8)% | 17% | 17% | —% | —% |
Fourth | First | Second | Third | Fourth | First | Second | Third | |||||||||||||||||||
quarter | quarter | quarter | quarter | quarter | quarter | quarter | quarter | |||||||||||||||||||
2023 | 2024 | 2024 | 2024 | 2024 | 2025 | 2025 | 2025 | |||||||||||||||||||
Revenue | $ | 63,680 | $ | 63,028 | $ | 62,276 | $ | 61,046 | $ | 60,934 | $ | 60,150 | $ | 59,113 | $ | 58,067 | ||||||||||
Gross Profit | $ | 42,241 | $ | 44,028 | $ | 43,986 | $ | 43,000 | $ | 41,807 | $ | 41,181 | $ | 40,488 | $ | 40,039 | ||||||||||
Operating Expenses1 |
$ | 43,708 | $ | 45,001 | $ | 44,537 | $ | 42,745 | $ | 41,600 | $ | 42,056 | $ | 41,296 | $ | 40,605 | ||||||||||
Net loss | $ | (23,630) | $ | (2,444) | $ | (3,239) | $ | (1,268) | $ | (1,708) | $ | (1,910) | $ | (1,881) | $ | (1,428) | ||||||||||
Net loss per share | ||||||||||||||||||||||||||
Basic and diluted basis | $ | (0.72) | $ | (0.07) | $ | (0.10) | $ | (0.04) | $ | (0.05) | $ | (0.06) | $ | (0.06) | $ | (0.04) | ||||||||||
Free cash flow | $ | 8,246 | $ | 5,249 | $ | 6,757 | $ | 13,023 | $ | 8,305 | $ | 10,012 | $ | 9,786 | $ | 8,355 | ||||||||||
Free cash flow per share (basic & diluted) | $ | 0.25 | $ | 0.16 | $ | 0.20 | $ | 0.39 | $ | 0.25 | $ | 0.30 | $ | 0.29 | $ | 0.25 | ||||||||||
Adjusted EBITDA | $ | 10,860 | $ | 9,882 | $ | 10,448 | $ | 11,155 | $ | 11,110 | $ | 9,814 | $ | 10,088 | $ | 9,772 | ||||||||||
AEBITDA % Revenue | 17 | % | 16 | % | 17 | % | 18 | % | 18 | % | 16 | % | 17 | % | 17 | % | ||||||||||
change % | (1) | % | 1 | % | 1 | % | — | % | (2) | % | 1 | % | — | % |
$ | |||||
Opening balance, July 1, 2023 |
14,551 | ||||
Revenue deferred during the period |
38,500 | ||||
Deferred revenue recognized as revenue during the period |
(40,397) | ||||
Ending balance, June 30, 2024 |
12,654 | ||||
Revenue deferred during the period |
27,909 | ||||
Deferred revenue recognized as revenue during the period |
(30,719) | ||||
Ending balance, March 31, 2025 |
9,844 | ||||
Contract liabilities - Current | 7,130 | ||||
Contract liabilities - Non-current | 2,714 | ||||
9,844 |
within 12 months | 13-24 months | 25-36 months | >37 months | Total | |||||||||||||
$ | $ | $ | $ | $ | |||||||||||||
Accounts payable and accrued liabilities | 19,007 | — | — | — | 19,007 | ||||||||||||
Sales tax payable | 4,050 | — | — | — | 4,050 | ||||||||||||
Operating facility and loans | 20,600 | 20,600 | 11,850 | — | 53,050 | ||||||||||||
Lease obligations on right of use assets | 2,303 | 1,792 | 1,348 | 4,782 | 10,225 | ||||||||||||
Other non-current liabilities | — | — | — | 1,887 | 1,887 | ||||||||||||
45,960 | 22,392 | 13,198 | 6,669 | 88,219 |
Unaudited in US $000 | Three month periods ended March 31, |
Nine month periods ended March 31, |
||||||||||||||||||||||||
2025 | 2024 | Change | Change | 2025 | 2024 | Change | Change | |||||||||||||||||||
$ | $ | $ | % | $ | $ | $ | % | |||||||||||||||||||
Net loss | (1,428) | (1,268) | (160) | 13% | (5,219) | (6,951) | 1,732 | (25)% | ||||||||||||||||||
Tax expense (recovery) | (281) | (195) | (86) | 44% | (898) | (1,186) | 288 | (24)% | ||||||||||||||||||
Interest expense (net) | 871 | 1,718 | (847) | (49)% | 3,354 | 5,175 | (1,821) | (35)% | ||||||||||||||||||
Share-based compensation | 517 | 764 | (247) | (32)% | 2,283 | 2,282 | 1 | —% | ||||||||||||||||||
Depreciation of property and equipment | 982 | 1,169 | (187) | (16)% | 3,073 | 3,292 | (219) | (7)% | ||||||||||||||||||
Depreciation of right-of-use assets | 640 | 716 | (76) | (11)% | 1,971 | 2,206 | (235) | (11)% | ||||||||||||||||||
Amortization of intangibles | 8,199 | 8,251 | (52) | (1)% | 24,596 | 24,974 | (378) | (2)% | ||||||||||||||||||
Restructuring and business integration costs | 272 | — | 272 | 100% | 514 | 1,491 | (977) | (66)% | ||||||||||||||||||
Loss on change in fair value of consideration payable | — | — | — | —% | — | 202 | (202) | (100)% | ||||||||||||||||||
Adjusted EBITDA | 9,772 | 11,155 | (1,383) | (12)% | 29,674 | 31,485 | (1,811) | (6)% | ||||||||||||||||||
Percentage of revenue | 16.8% | 18.3% | (1.4)% | (8)% | 16.7% | 16.9% | —% | —% |
Unaudited in US $000 | Three month periods ended March 31, |
Nine month periods ended March 31, |
||||||||||||||||||||||||
2025 | 2024 | Change | Change | 2025 | 2024 | Change | Change | |||||||||||||||||||
$ | $ | $ | % | $ | $ | $ | % | |||||||||||||||||||
Net cash provided by operating activities | 10,620 | 15,506 | (4,886) | (32)% | 34,660 | 32,543 | 2,117 | 7% | ||||||||||||||||||
Purchase of property and equipment | (622) | (1,061) | 439 | (41)% | (1,569) | (2,695) | 1,126 | (42)% | ||||||||||||||||||
Development costs | (1,643) | (1,422) | (221) | 16% | (4,938) | (4,819) | (119) | 2% | ||||||||||||||||||
Free Cash Flow | 8,355 | 13,023 | (4,668) | (36)% | 28,153 | 25,029 | 3,124 | 12% |
/s/ Larry Stock | ||
Chief Financial Officer |